| 注册
首页|期刊导航|器官移植|高 MELD 评分终末期肝病患者接受中国公民逝世后器官捐献供肝肝移植的近期疗效评价

高 MELD 评分终末期肝病患者接受中国公民逝世后器官捐献供肝肝移植的近期疗效评价

邓斐文 陈焕伟 甄作均 计勇 陈应军 王峰杰 吴志鹏 李杰原 胡健垣

器官移植Issue(2):86-92,7.
器官移植Issue(2):86-92,7.DOI:10.3969/j.issn.1674-7445.2015.02.004

高 MELD 评分终末期肝病患者接受中国公民逝世后器官捐献供肝肝移植的近期疗效评价

Short-term clinical efficacy of liver transplantation with organs from donation after Chinese citizens’ death in patients with high model for end-stage liver disease score

邓斐文 1陈焕伟 1甄作均 1计勇 1陈应军 1王峰杰 1吴志鹏 1李杰原 1胡健垣1

作者信息

  • 1. 528000 广东佛山市第一人民医院肝脏胰腺外科
  • 折叠

摘要

Abstract

group was significantly longer than that in the low MELD score group (P <0.05).And there was no significant difference in the length of hospital stay,mortality during hospitalization,incidence of early complications, follow-up time and overall survival rate between two groups (all in P >0.05).The peak level of aspartate aminotransferase (AST)in the high MELD score group was significantly higher compared with that in the low MELD score group (P <0.05 ).The incidence of bile leakage,abdominal abscess and liver dysfunction significantly differed between two groups (all in P <0.05 ).Conclusions It is a safe and short-term efficacious approach to perform liver transplantation with organs obtained from Chinese donation after citizens’ death in patients with high MELD score liver recipients.

关键词

心脏死亡器官捐献/终末期肝病模型/肝移植

Key words

Donation after cardiac death/Model for end-stage liver disease/Liver transplantation

分类

医药卫生

引用本文复制引用

邓斐文,陈焕伟,甄作均,计勇,陈应军,王峰杰,吴志鹏,李杰原,胡健垣..高 MELD 评分终末期肝病患者接受中国公民逝世后器官捐献供肝肝移植的近期疗效评价[J].器官移植,2015,(2):86-92,7.

基金项目

广东省医学科研基金(A2014697);佛山市医学类科技攻关项目(2014AB00263);佛山市卫生局医学科研基金 ()

器官移植

OACSCDCSTPCD

1674-7445

访问量0
|
下载量0
段落导航相关论文